HLB bioStep Non-Registered Executive Lee Hyeong-seok Increases Stake by 4,987 Shares in Open Market, Insider Ownership Now at 0.05%

HLB bioStep non-registered executive Lee Hyeong-seok purchased 4,987 common shares via open market on July 14, 2026, at an average price of 2,005 KRW, increasing his total holdings to 7,987 shares representing 0.05% of outstanding shares.
While insider buying typically signals management confidence in the company's value, the small scale of this transaction relative to total market capitalization of 36.6 billion KRW limits its immediate market impact.
[AI Summary]Minor insider purchase by HLB bioStep executive shows management alignment but negligible ownership change; no capital structure alteration or shareholder return policy changes disclosed.